Related Experiment Video

Updated: Aug 18, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Third-line chemotherapy for advanced non-small-cell lung cancer--is there enough evidence to support its use?

Chih-Hsin Yang

    Journal of the Chinese Medical Association : JCMA
    |April 27, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    Related Experiment Videos

    Last Updated: Aug 18, 2026

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Multimodal radiomic analysis to determine high-Consistency prognostic phenotypes associated with epidermal growth factor receptor mutations in non-small cell lung cancer brain metastases.

    European journal of radiology·2025

    Hope and its relationship with treatment/ physical related factors in lung cancer patients receiving immunotherapy.

    Journal of the Formosan Medical Association = Taiwan yi zhi·2024

    Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.

    Oncotarget·2015

    High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country.

    PloS one·2015

    Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: an open-label single-arm study.

    Journal of the Formosan Medical Association = Taiwan yi zhi·2013

    Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells.

    Oncology reports·2012

    2026 Taiwan guidelines for the acute pharmacologic treatment of migraine in adults.

    Journal of the Chinese Medical Association : JCMA·2026

    Artificial intelligence in advanced liver disease: From risk stratification to decision.

    Journal of the Chinese Medical Association : JCMA·2026

    Identifying risk factors for procedural pain in outpatient hysteroscopy: A multivariable analysis.

    Journal of the Chinese Medical Association : JCMA·2026

    Decline in dementia patients during the COVID-19 pandemic: A cohort study in Taiwan.

    Journal of the Chinese Medical Association : JCMA·2026

    Early hearing improvement predicts complete recovery in sudden hearing loss.

    Journal of the Chinese Medical Association : JCMA·2026

    Surgical treatment of pulsatile tinnitus arising from sigmoid sinus wall anomalies.

    Journal of the Chinese Medical Association : JCMA·2026

    Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma.

    Oncogene·2026

    Fourier-based chemometric resolution of the FOLFOX regimen through digital filtering with poly-metric sustainability assessment.

    Scientific reports·2026

    Self-Enhancing Photodynamic / Immunotherapy via a MOF Nanoplatform for Combined STING Activation and Immune Checkpoint Blockade.

    Advanced healthcare materials·2026

    Comparative effectiveness and safety of carotid endarterectomy, carotid stenting, and optimal medical therapy across symptomatic and asymptomatic carotid stenosis: An updated network meta-analysis of randomized controlled trials.

    Cardiovascular revascularization medicine : including molecular interventions·2026

    Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma.

    European urology oncology·2026

    Digitally enabled patient-centred survivorship care: from hype to implementation-aware impact.

    The Lancet. Digital health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us